Theravance Biopharma Inc (STU:0TB)
€ 7.5 -0.1 (-1.32%) Market Cap: 372.08 Mil Enterprise Value: 326.63 Mil PE Ratio: 0 PB Ratio: 2.08 GF Score: 59/100

Q2 2020 Theravance Biopharma Inc Earnings Call Transcript

Aug 06, 2020 / 09:00PM GMT
Release Date Price: €17.3 (+2.98%)
Operator

Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma conference call. (Operator Instructions) Today's conference call is being recorded.

And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications and Investor Relations. Please go ahead.

Gail B. Cohen
Theravance Biopharma, Inc. - VP of Corporate Communications & IR

Good afternoon, everyone, and thank you for joining the Theravance Biopharma conference call and webcast to discuss our second quarter 2020 financial results and outlook.

As always, I remind you that this conference call will continue forward-looking statements, which involve certain risks and uncertainties, including statements about our product pipeline, expected benefits of our products, the anticipated timing of trial results and regulatory filings and expected sales and financial results. Information concerning factors that could cause results to differ materially from other forward-looking statements is described further in the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot